Any thoughts12 Nov 2019 09:19
On the recent RNS's re: investor presentations?
They are obviously looking for funding, but these two presentations appear to be aimed firmly at institutional investors so they are not going the discounted bucket-shop route.
One thought is what does this tell us about the 'global pharma deal', if anything? If we are about to receive a fat wedge of dolalrs from a them would they be going down this route as well? Maybe the two things are connected?